Skip to content

Randomized, controlled, clinical evaluation of xenogene bone and soft tissue substitute materials (PURGO THE Graft, PURGO THE Cover) in ridge preservation

Randomized, controlled, clinical evaluation of xenogene bone and soft tissue substitute materials (PURGO THE Graft, PURGO THE Cover) in ridge preservation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031642
Enrollment
108
Registered
2023-05-16
Start date
2023-06-16
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Sponsors

Purgo Biologics Inc.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with good hygienic oral conditions - Patients in need of extraction of one or more teeth; in case of more teeth the defect sites have to be in different quadrants - Patients with type 1 (intact alveolar) or type 2 sockets (compromised alveolar) - No systemic diseases which could influence the outcome of the therapy - Patients able to follow pre- and post-surgical instructions - Patient with informed consent

Exclusion criteria

Exclusion criteria: - Patients with severe systemic disease - Patients with uncontrolled diabetes - Allergies to product components - Untreated caries - Alcohol/ drug abuse - Patients not able to follow instructions - Patients w/o informed consent

Design outcomes

Primary

MeasureTime frame
Bone gain 3 months after ridge preservation procedure, evaluated via image analysis of radiological images compared to post-extraction

Secondary

MeasureTime frame
1. Pain (VAS) - 7 days post extraction 2. Soft tissue healing up to 3 months after ridge preservation, evaluated via semi-quantitative image analysis of clinical photo documentation 3. Bone quality via Implant success and stability at implantation surgery 3 months post-extraction 4. Implant survival after 3 years 5. Radiological evaluation of bone change at augmentation/implant site after 3 years, compared to post-extraction and pre-implantation situation 6. Occurrence of complications (e.g. infection, periimplantitis, implant loss) 7. Evaluation of safety measures via occurrence of (S)AE ((serious) adverse events), and medical device related events up to 3 months post-extraction

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026